Haviland Kate
- SEC CIK
- 0001663022
No open-market purchases or sales filed in the past year.
Current role at each company
- FULC Fulcrum Therapeutics, Inc.Directoras of Jul 2, 2026
- BCAX Bicara Therapeutics Inc.Directoras of Jun 10, 2026
- AVLN Avalyn Pharma Inc.Directoras of May 1, 2026
- BPMC Blueprint Medicines CorpChief Executive Officeras of Jul 21, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Haviland Kate as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BPMC Blueprint Medicines Corp
Chief Executive Officer10 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2025 (view filing) | Apr 1 | 2 days | Haviland KateCHIEF EXECUTIVE OFFICER | SSale | −2.50K | $86.65 | −$216.5K | −1.5%165.9K after | 4 lots10b5-1 |
| Mar 7, 2025 (view filing) | Mar 5 | 2 days | Haviland KateCHIEF EXECUTIVE OFFICER | SSale | −16.2K | $88.80 | −$1.43M | −8.8%168.4K after | |
| Jan 23, 2025 (view filing) | Jan 21 | 2 days | Haviland KateCHIEF EXECUTIVE OFFICER | SSale | −1.45K | $110.24 | −$159.4K | −1.0%149.4K after | 10b5-1 |
| Dec 3, 2024 (view filing) | Nov 29 | 4 days | Haviland KateCHIEF EXECUTIVE OFFICER | SSale | −2.35K | $96.60 | −$227.3K | −1.5%150.8K after | 3 lots10b5-1 |
| Mar 11, 2024 (view filing) | Mar 7 | 4 days | Haviland KateCHIEF EXECUTIVE OFFICER | SSale | −12.5K | $90.69 | −$1.13M | −7.5%153.2K after | |
| Mar 8, 2023 (view filing) | Mar 6 | 2 days | Haviland KateCHIEF EXECUTIVE OFFICER | SSale | −6.64K | $45.69 | −$303.4K | −5.0%125.6K after | 2 lots |
| Nov 7, 2022 (view filing) | Nov 3 | 4 days | Haviland KateCHIEF EXECUTIVE OFFICER | PPurchase | +1.10K | $43.98 | +$48.4K | +1.2%92.3K after | |
| Mar 8, 2022 (view filing) | Mar 3-7 | 5 daysLate | Haviland KateCHIEF OPERATING OFFICER | SSale | −2.77K | $58.72 | −$162.5K | −2.9%91.2K after | 2 lots |
| Dec 15, 2021 (view filing) | Dec 13 | 2 days | Haviland KateChief Operating Officer | SSale | −1.00K | $98.30 | −$98.3K | −1.8%53.9K after | 4 lots |
| Sep 15, 2021 (view filing) | Sep 13 | 2 days | Haviland KateChief Operating Officer | SSale | −1.00K | $99.94 | −$99.9K | −1.8%53.9K after | 5 lots |